Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROUD: Truvada PrEP for HIV Prevention
NCT02065986Phase 4Completed
- Sponsor
- Medical Research Council
- Start
- Oct 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Medical Research Council. Started Oct 2012; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02065986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065986.